Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia.
Saved in:
| Title: | Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. |
|---|---|
| Authors: | Spinler K; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States., Hamilton M; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States., Bajaj J; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States., Shima Y; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States., Diaz E; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States., Kritzik M; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States.; Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States., Reya T; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States.; Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States. |
| Source: | ELife [Elife] 2026 Jan 07; Vol. 13. Date of Electronic Publication: 2026 Jan 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41498402 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Spinler+K%22">Spinler K</searchLink>; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.<br /><searchLink fieldCode="AU" term="%22Hamilton+M%22">Hamilton M</searchLink>; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.<br /><searchLink fieldCode="AU" term="%22Bajaj+J%22">Bajaj J</searchLink>; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.<br /><searchLink fieldCode="AU" term="%22Shima+Y%22">Shima Y</searchLink>; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.<br /><searchLink fieldCode="AU" term="%22Diaz+E%22">Diaz E</searchLink>; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.<br /><searchLink fieldCode="AU" term="%22Kritzik+M%22">Kritzik M</searchLink>; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States.; Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States.<br /><searchLink fieldCode="AU" term="%22Reya+T%22">Reya T</searchLink>; Departments of Pharmacology and Medicine, University of California San Diego School of Medicine La Jolla, San Diego, United States.; Moores Cancer Center, University of California San Diego School of Medicine, San Diego, United States.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States.; Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2026 Jan 07; Vol. 13. <i>Date of Electronic Publication: </i>2026 Jan 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41498402 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.93645 Languages: – Code: eng Text: English Titles: – TitleFull: Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spinler K – PersonEntity: Name: NameFull: Hamilton M – PersonEntity: Name: NameFull: Bajaj J – PersonEntity: Name: NameFull: Shima Y – PersonEntity: Name: NameFull: Diaz E – PersonEntity: Name: NameFull: Kritzik M – PersonEntity: Name: NameFull: Reya T IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 01 Text: 2026 Jan 07 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 13 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |